NCT03731949 is a clinical trial of Ultrasonography in Placenta Diseases, sponsored by Aljazeera Hospital.

Who is sponsoring NCT03731949?

NCT03731949 is sponsored by Aljazeera Hospital.

What drugs are being tested in NCT03731949?

Interventions in NCT03731949: Ultrasonography.

What condition does NCT03731949 study?

NCT03731949 studies Placenta Diseases.

Is NCT03731949 still recruiting?

NCT03731949 is currently status unknown. Last updated 10 January 2019.

Last reviewed 2019-01-10 · How we verify

NCT03731949

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Placental Volume Analysis During Pregnanay

Status unknown Last updated 10 January 2019

What this trial tests

trial testing Ultrasonography in Placenta Diseases in 500 participants. Status unknown.

Timeline

16 November 2018

Primary endpoint
1 June 2019

5 July 2019

Quick facts

Lead sponsor	Aljazeera Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	16 November 2018
Primary completion	1 June 2019
Estimated completion	5 July 2019
Sites	1 location across Egypt

Drugs / interventions tested

Ultrasonography

Conditions studied

Placenta Diseases — all drugs for Placenta Diseases →

Sponsor

Aljazeera Hospital

Who can join

Adults 20 to 40, female only, with Placenta Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Placenta grows with advancing gestational age amonitoring of placental growth is important in pregnancy evaluation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ultrasonography

Trials testing the same drug.

NCT07406061 — Ultrasound Imaging of the Head, Neck, and Airway · not yet recruiting
NCT07144501 — Prevalence of Liver Dysfunction in Pediatric Patients With Congenital Heart Disease at Assiut. · NA · not yet recruiting
NCT06492603 — Examination of Biomechanical Characteristics of Linea Alba in Diastasis Recti Patients · not yet recruiting
NCT02492932 — The Second Try During Landmark Approach of the Internal Jugular Vein: an Ultrasonographic Prelocation Study · NA · not yet recruiting
NCT06778005 — Investigation of Ultrasonographic Measurements of Lower Extremity Nerves in Type 2 Diabetes Patients With Peripheral Pol · recruiting

Other recruiting trials for Placenta Diseases

Currently open trials in the same condition.

NCT06352970 — Effects of Tuberculosis Infection on Development and Function of the Placenta · recruiting

Other Aljazeera Hospital trials

Trials by the same sponsor.

NCT06739759 — Ovarian Hyperstimulation Syndrome Prevention · NA · recruiting
NCT04778319 — Hysterosalpingography and Hysteroscopy in ICSI · NA · unknown
NCT04736095 — 3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas · completed
NCT04749979 — Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin · NA · unknown
NCT04694677 — Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy. · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03731949 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aljazeera Hospital
Last refreshed: 10 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03731949.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing